TriptoBIO ApS: Financial statements 2023
CVR: 43307495
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
TriptoBIO ApS (CVR 43307495) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -854,685 and a net result of DKK -3,212,101. Equity in the 2023 report amounted to DKK -3,192,820. The company had 5 employees in the financial year.
- Gross Profit
- DKK -854,685
- Profit/Loss
- DKK -3,212,101
- Equity
- DKK -3,192,820
- Total Assets
- DKK 10,719,982
- Employees
- 5
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of July 29, 2023, Jon Rune Christensen has joined the board of directors of TriptoBIO ApS.
As of July 29, 2023, Johan Andersen-Ranberg has joined the board of directors of TriptoBIO ApS.
TriptoBIO ApS has published its interim report for the period May 30, 2022 – December 31, 2022.
About TriptoBIO ApS
TriptoBIO ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jon Rune Christensen and Johan Andersen-Ranberg. The company is owned by JRC Holding HL ApS and JAR ApS. In 2025, the company reported a gross profit of DKK -54,353 and a net result of DKK -4,175,620 compared with DKK -4,449,073 the year before. Equity in the 2025 report amounted to DKK -11,817,513.